PMID- 32579245 OWN - NLM STAT- MEDLINE DCOM- 20210621 LR - 20210621 IS - 1537-2995 (Electronic) IS - 0041-1132 (Linking) VI - 60 IP - 8 DP - 2020 Aug TI - Blood utilization and characteristics of patients treated with chronic transfusion therapy in a large cohort of Brazilian patients with sickle cell disease. PG - 1713-1722 LID - 10.1111/trf.15818 [doi] AB - BACKGROUND: Red blood cell (RBC) transfusions are used in sickle cell disease (SCD) to treat acute complications or as chronic transfusion therapy (CTT) to prevent severe manifestations. The objectives of this study were to describe blood utilization and adverse events (AEs) associated with RBCs in the Brazilian SCD population and compare characteristics of patients treated or not with CTT. STUDY DESIGN AND METHODS: A SCD cohort was established at six Brazilian centers. Medical and blood bank records were abstracted for clinical and transfusion history. Two controls not treated with CTT matched on center, SCD genotype, sex, and age were selected for each CTT case within the cohort to compare characteristics between the two groups. RESULTS: Most of the 2794-member cohort had received a transfusion (75.0% of children and 89.2% of adults) with 29.2% of patients receiving transfusion in the prior year. There were 170 (10.6%) children and 115 (9.2%) adults treated with CTT. Children not treated with CTT were more likely to have pain and acute chest hospitalizations in the prior year (25.3% vs. 11.9%, p = 0.0003; and 22.0% vs. 10.7%, p = 0.002, respectively). Both iron overload and alloimmunization were more common in CTT cases compared to controls (65.6% vs. 17.0% and 36.2% vs. 15.9%, respectively). A higher proportion of adults treated with CTT demonstrated oxygen saturation of greater than 95% compared to controls not treated (51.1% vs. 39.2%), while there was no difference in oxygenation between children treated or not. Of 4501 transfusion episodes, 28 (0.62%) AEs were reported. There was no difference in AEs associated with transfusions for acute indications versus CTT. CONCLUSION: Red blood cell transfusion was common in Brazilian SCD patients, with utilization driven by CTT. Transfusion reactions were not common; however, alloimmunization and iron overload were frequent among those on CTT, highlighting the need for novel clinical strategies to mitigate these risks. CI - (c) 2020 AABB. FAU - Kelly, Shannon AU - Kelly S AUID- ORCID: 0000-0003-2049-3992 AD - Vitalant Research Institute, San Francisco, California, USA. AD - UCSF Benioff Children's Hospital Oakland, Oakland, California, USA. FAU - Belisario, Andre Rolim AU - Belisario AR AUID- ORCID: 0000-0003-0166-4258 AD - Fundacao Hemominas/Minas Gerais Hemocenter, Minas Gerais, Brazil. FAU - Werneck Rodrigues, Daniela O AU - Werneck Rodrigues DO AD - Fundacao Hemominas/Minas Gerais Hemocenter, Minas Gerais, Brazil. FAU - Carneiro-Proietti, Anna B F AU - Carneiro-Proietti ABF AD - Fundacao Hemominas/Minas Gerais Hemocenter, Minas Gerais, Brazil. FAU - Goncalez, Thelma T AU - Goncalez TT AD - Vitalant Research Institute, San Francisco, California, USA. FAU - Loureiro, Paula AU - Loureiro P AD - Hemope/University of Pernambuco, Recife, Pernambuco, Brazil. FAU - Flor-Park, Miriam V AU - Flor-Park MV AD - Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Instituto da Crianca, Sao Paulo, Brazil. FAU - Maximo, Claudia AU - Maximo C AD - Hemorio, Rio de Janeiro Hemocenter, Rio de Janeiro, Brazil. FAU - Mota, Rosimere Afonso AU - Mota RA AD - Vitalant Research Institute, San Francisco, California, USA. FAU - Dinardo, Carla AU - Dinardo C AUID- ORCID: 0000-0002-0453-7863 AD - Pro-Sangue, Sao Paulo Hemocenter, Sao Paulo, Brazil. AD - Institute of Tropical Medicine, University of Sao Paulo, Sao Paulo, Brazil. FAU - Brambilla, Don AU - Brambilla D AUID- ORCID: 0000-0002-7276-4689 AD - Research Triangle Institute (RTI) International, Triangle Park, North Carolina, USA. FAU - Preiss, Liliana AU - Preiss L AD - Research Triangle Institute (RTI) International, Triangle Park, North Carolina, USA. FAU - Sabino, Ester AU - Sabino E AUID- ORCID: 0000-0003-2623-5126 AD - Institute of Tropical Medicine, University of Sao Paulo, Sao Paulo, Brazil. FAU - Custer, Brian AU - Custer B AD - Fundacao Hemominas/Minas Gerais Hemocenter, Minas Gerais, Brazil. AD - Department of Laboratory Medicine, University of California at San Francisco, San Francisco, California, USA. CN - NHLBI Recipient Epidemiology Donor Evaluation Study (REDS-III) International Component-Brazil LA - eng PT - Clinical Trial PT - Journal Article PT - Multicenter Study DEP - 20200624 PL - United States TA - Transfusion JT - Transfusion JID - 0417360 RN - S88TT14065 (Oxygen) SB - IM MH - *Acute Chest Syndrome/blood/epidemiology/therapy MH - Adolescent MH - Adult MH - Age Factors MH - Brazil/epidemiology MH - Child MH - Child, Preschool MH - Erythrocyte Transfusion/*adverse effects MH - Female MH - Humans MH - *Iron Overload/blood/epidemiology/etiology MH - Male MH - Oxygen/*blood MH - Sex Factors MH - *Transfusion Reaction/blood/epidemiology EDAT- 2020/06/25 06:00 MHDA- 2021/06/22 06:00 CRDT- 2020/06/25 06:00 PHST- 2019/04/15 00:00 [received] PHST- 2020/01/13 00:00 [revised] PHST- 2020/01/13 00:00 [accepted] PHST- 2020/06/25 06:00 [pubmed] PHST- 2021/06/22 06:00 [medline] PHST- 2020/06/25 06:00 [entrez] AID - 10.1111/trf.15818 [doi] PST - ppublish SO - Transfusion. 2020 Aug;60(8):1713-1722. doi: 10.1111/trf.15818. Epub 2020 Jun 24.